pI: 9.256 |
Length (AA): 397 |
MW (Da): 46445 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
143 | 394 | 4ar9 (A) | 369 | 612 | 14.00 | 0 | 0.02 | 0.701064 | -0.14 |
152 | 231 | 5vgb (A) | 34 | 121 | 31.00 | 0.61 | 0.15 | 0.46142 | -0.43 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128523)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_18665 | Receptor family ligand binding region containing protein |
Caenorhabditis elegans | CELE_T01A4.1 | Protein GCY-28, isoform B |
Caenorhabditis elegans | CELE_F08B1.2 | Protein GCY-12 |
Drosophila melanogaster | Dmel_CG3216 | CG3216 gene product from transcript CG3216-RD |
Drosophila melanogaster | Dmel_CG31183 | CG31183 gene product from transcript CG31183-RB |
Drosophila melanogaster | Dmel_CG42637 | CG42637 gene product from transcript CG42637-RB |
Drosophila melanogaster | Dmel_CG33114 | Guanyl cyclase at 32E |
Drosophila melanogaster | Dmel_CG10738 | CG10738 gene product from transcript CG10738-RD |
Drosophila melanogaster | Dmel_CG42636 | Guanylyl cyclase at 76C |
Echinococcus granulosus | EgrG_000986200 | atrial natriuretic peptide receptor |
Echinococcus granulosus | EgrG_000986400 | receptor type guanylyl cyclase |
Echinococcus multilocularis | EmuJ_000986400 | receptor type guanylyl cyclase |
Echinococcus multilocularis | EmuJ_000986200 | atrial natriuretic peptide receptor |
Homo sapiens | ENSG00000169418 | natriuretic peptide receptor 1 |
Homo sapiens | ENSG00000159899 | natriuretic peptide receptor 2 |
Loa Loa (eye worm) | LOAG_04414 | RGC/RGC protein kinase |
Loa Loa (eye worm) | LOAG_03564 | RGC/RGC protein kinase |
Mus musculus | ENSMUSG00000027931 | natriuretic peptide receptor 1 |
Mus musculus | ENSMUSG00000028469 | natriuretic peptide receptor 2 |
Mycobacterium ulcerans | MUL_3594 | adenylylate/guanylate cyclase |
Onchocerca volvulus | OVOC385 | Atrial natriuretic peptide receptor 3 homolog |
Schistosoma japonicum | Sjp_0114000 | expressed protein |
Schistosoma japonicum | Sjp_0006560 | expressed protein |
Schistosoma japonicum | Sjp_0006550 | Atrial natriuretic peptide receptor A precursor, putative |
Schistosoma japonicum | Sjp_0062410 | IPR001828,Extracellular ligand-binding receptor,domain-containing |
Schistosoma mansoni | Smp_142620 | protein kinase |
Schmidtea mediterranea | mk4.001543.05 | |
Schmidtea mediterranea | mk4.022301.01 | |
Schmidtea mediterranea | mk4.025584.00 | Atrial natriuretic peptide receptor 3 |
Schmidtea mediterranea | mk4.025892.01 | |
Schmidtea mediterranea | mk4.034231.00 | |
Schmidtea mediterranea | mk4.012081.01 | |
Schmidtea mediterranea | mk4.007620.01 | Atrial natriuretic peptide receptor 3 |
Schmidtea mediterranea | mk4.020674.00 | |
Schmidtea mediterranea | mk4.011603.02 | |
Schmidtea mediterranea | mk4.002201.02 | |
Schmidtea mediterranea | mk4.019304.01 | |
Schmidtea mediterranea | mk4.017097.02 | |
Schmidtea mediterranea | mk4.025584.02 | |
Schmidtea mediterranea | mk4.002201.01 | Guanylate cyclase |
Schmidtea mediterranea | mk4.012081.02 | |
Schmidtea mediterranea | mk4.001829.01 | Head-specific guanylate cyclase |
Schmidtea mediterranea | mk4.027466.00 | |
Schmidtea mediterranea | mk4.034231.01 | |
Schmidtea mediterranea | mk4.010101.01 | |
Schmidtea mediterranea | mk4.025892.00 | |
Schmidtea mediterranea | mk4.003720.03 | |
Schmidtea mediterranea | mk4.046362.00 | |
Schmidtea mediterranea | mk4.021664.00 | |
Schmidtea mediterranea | mk4.007531.00 | |
Schmidtea mediterranea | mk4.027083.00 | |
Schmidtea mediterranea | mk4.030173.00 | |
Schmidtea mediterranea | mk4.035591.01 | |
Schmidtea mediterranea | mk4.034765.00 | Atrial natriuretic peptide receptor 3 |
Schmidtea mediterranea | mk4.025892.02 | Atrial natriuretic peptide receptor 3 |
Schmidtea mediterranea | mk4.011855.00 | |
Schmidtea mediterranea | mk4.015654.01 | |
Schmidtea mediterranea | mk4.054784.00 | |
Schmidtea mediterranea | mk4.022313.01 | |
Schmidtea mediterranea | mk4.026349.00 | |
Schmidtea mediterranea | mk4.027874.00 | |
Schmidtea mediterranea | mk4.010268.00 | |
Schmidtea mediterranea | mk4.025584.01 | |
Schmidtea mediterranea | mk4.011603.01 | |
Schmidtea mediterranea | mk4.017097.00 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_F08B1.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | natriuretic peptide receptor 2 | Compounds | References |
Homo sapiens | natriuretic peptide receptor 1 | Compounds | References |
Bos taurus | Atrial natriuretic peptide receptor B | Compounds | References |